eli lilly & co (LLY:Euronext Paris)
Transactions by ELI LILLY & CO (LLY) in the last 6 months
Zosano Pharma Corporation (NasdaqCM:ZSAN) announced that it has entered into common stock purchase agreement with new investor, Eli Lilly and Company for a private placement of 1,363,636 common shares at $11 per share for gross proceeds of $15,000,000 on November 21, 2014. The shares to be issued in the transaction have a par value of $0.0001 per share. The company paid fees of $525,000 equal to 3.5% in connection with the transaction. The company will issue securities ...
Virbac SA (ENXTPA:VIRP) entered into an agreement to acquire United States Veterinary products from Eli Lilly and Company (NYSE:LLY) on October 27, 2014. Under the terms of this agreement, Virbac would acquire a combination of titles and rights for the United States on trademarks, marketing authorizations, patents, know-how, customer lists and other assets, related to two major parasiticides, Sentinel®Flavor Tabs and Sentinel® Spectrum. The transaction is subject to ...
|Amgen Inc||$162.59 USD||+2.04|
|AstraZeneca PLC||4,686 GBp||-5.00|
|Bristol-Myers Squibb Co||$65.26 USD||+0.26|
|Novo Nordisk A/S||kr369.70 DKK||+34.70|
|Teva Pharmaceutical Industries Ltd||$61.98 USD||-0.44|
|View Industry Companies|